128 related articles for article (PubMed ID: 17566084)
41. Chromogranin A (CGA)-derived polypeptide (CGA
Luo L; Liu S; Zhang D; Wei F; Gu N; Zeng Y; Chen X; Xu S; Liu S; Xiang T
Peptides; 2020 Sep; 131():170297. PubMed ID: 32380199
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
[TBL] [Abstract][Full Text] [Related]
43. Development of an Atlantic salmon heart endothelial cell line (ASHe) that responds to lysophosphatidic acid (LPA).
Pham PH; Vo NT; Tan EJ; Russell S; Jones G; Lumsden JS; Bols NC
In Vitro Cell Dev Biol Anim; 2017 Jan; 53(1):20-32. PubMed ID: 27586265
[TBL] [Abstract][Full Text] [Related]
44. A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway.
Wei R; Wu Q; Ai N; Wang L; Zhou M; Shaw C; Chen T; Ye RD; Ge W; Siu SWI; Kwok HF
Comput Struct Biotechnol J; 2021; 19():2664-2675. PubMed ID: 34093983
[TBL] [Abstract][Full Text] [Related]
45. Association between preoperative Vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET).
Andreasi V; Partelli S; Manzoni M; Muffatti F; Colombo B; Corti A; Falconi M
Pancreatology; 2019 Jan; 19(1):57-63. PubMed ID: 30470614
[TBL] [Abstract][Full Text] [Related]
46. Regulatory peptides from chromogranin A and secretogranin II.
Helle KB
Cell Mol Neurobiol; 2010 Nov; 30(8):1145-6. PubMed ID: 21088887
[TBL] [Abstract][Full Text] [Related]
47. Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).
Jitpean S; Stridsberg M; Pettersson A; Höglund OV; Holst BS; Hagman R
BMC Vet Res; 2015 Jan; 11():14. PubMed ID: 25636335
[TBL] [Abstract][Full Text] [Related]
48. The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions.
Helle KB
Cardiovasc Res; 2010 Jan; 85(1):9-16. PubMed ID: 19640932
[TBL] [Abstract][Full Text] [Related]
49. Chromogranin A and the tumor microenvironment.
Corti A
Cell Mol Neurobiol; 2010 Nov; 30(8):1163-70. PubMed ID: 21080056
[TBL] [Abstract][Full Text] [Related]
50. Binding of ATP to vascular endothelial growth factor isoform VEGF-A165 is essential for inducing proliferation of human umbilical vein endothelial cells.
Gast RE; König S; Rose K; Ferenz KB; Krieglstein J
BMC Biochem; 2011 May; 12():28. PubMed ID: 21619628
[TBL] [Abstract][Full Text] [Related]
51. Isolation and characterization of rat pituitary endothelial cells.
Chaturvedi K; Sarkar DK
Neuroendocrinology; 2006; 83(5-6):387-93. PubMed ID: 17028416
[TBL] [Abstract][Full Text] [Related]
52. Neutrophil Elastase-Generated Fragment of Vascular Endothelial Growth Factor-A Stimulates Macrophage and Endothelial Progenitor Cell Migration.
Kurtagic E; Rich CB; Buczek-Thomas JA; Nugent MA
PLoS One; 2015; 10(12):e0145115. PubMed ID: 26672607
[TBL] [Abstract][Full Text] [Related]
53. Role of vasostatin-1 C-terminal region in fibroblast cell adhesion.
Dondossola E; Gasparri A; Bachi A; Longhi R; Metz-Boutigue MH; Tota B; Helle KB; Curnis F; Corti A
Cell Mol Life Sci; 2010 Jun; 67(12):2107-18. PubMed ID: 20217454
[TBL] [Abstract][Full Text] [Related]
54. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.
Lugardon K; Raffner R; Goumon Y; Corti A; Delmas A; Bulet P; Aunis D; Metz-Boutigue MH
J Biol Chem; 2000 Apr; 275(15):10745-53. PubMed ID: 10753865
[TBL] [Abstract][Full Text] [Related]
55. Expression and purification of soluble non-fusion vasostatin in Escherichia coli.
Wu X; Li X; Su Z; Zheng Q; Xu H; Wu S; Feng Y; Zhao W
Protein Pept Lett; 2005 Oct; 12(7):659-61. PubMed ID: 16522180
[TBL] [Abstract][Full Text] [Related]
56. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
Mahata SK; Corti A
Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
[TBL] [Abstract][Full Text] [Related]
57. [Cells of endothelial lineage (or endothelial-like cells) as possible progenitor cells of sarcomas induced by implanted foreign body].
Moĭzhess TG; Vasil'ev IuM
Tsitologiia; 2013; 55(8):548-52. PubMed ID: 25486786
[TBL] [Abstract][Full Text] [Related]
58. Chromogranin A: a paradoxical player in angiogenesis and vascular biology.
Helle KB; Corti A
Cell Mol Life Sci; 2015 Jan; 72(2):339-48. PubMed ID: 25297920
[TBL] [Abstract][Full Text] [Related]
59. Endothelium dependent cardiovascular effects of the Chromogranin A-derived peptides Vasostatin-1 and Catestatin.
Fornero S; Bassino E; Gallo MP; Ramella R; Levi R; Alloatti G
Curr Med Chem; 2012; 19(24):4059-67. PubMed ID: 22834796
[TBL] [Abstract][Full Text] [Related]
60. Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death.
Koshimizu H; Cawley NX; Yergy AL; Loh YP
J Mol Neurosci; 2011 Oct; 45(2):294-303. PubMed ID: 21537909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
